1 – 10 of 15
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Cost-effectiveness of romosozumab for the treatment of postmenopausal women with severe osteoporosis at high risk of fracture in Sweden
(
- Contribution to journal › Article
- 2018
-
Mark
A health economic simulation model for the clinical management of osteoporosis
(
- Contribution to journal › Article
- 2015
-
Mark
Health economic aspects of vertebral augmentation procedures
(
- Contribution to journal › Scientific review
- 2007
-
Mark
Latitude, socioeconomic prosperity, mobile phones and hip fracture risk.
(
- Contribution to journal › Article
-
Mark
Cost-effectiveness of alendronate in the treatment of postmenopausal women in 9 European countries - an economic evaluation based on the fracture intervention trial
(
- Contribution to journal › Article
- 2006
-
Mark
At what hip fracture risk is it cost-effective to treat? International intervention thresholds for the treatment of osteoporosis
(
- Contribution to journal › Article
-
Mark
The cost-effectiveness of risedronate in the treatment of osteoporosis: an international perspective
(
- Contribution to journal › Article
-
Mark
Costs and quality of life associated with osteoporosis-related fractures in Sweden
(
- Contribution to journal › Article
- 2005
-
Mark
Cost-effectiveness of raloxifene in the UK: an economic evaluation based on the MORE study
(
- Contribution to journal › Article
-
Mark
Intervention thresholds for osteoporosis in men and women: a study based on data from Sweden
(
- Contribution to journal › Article